These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372 [TBL] [Abstract][Full Text] [Related]
7. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial. von Birgelen C; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Gin RMTJ; Somi S; van Houwelingen KG; Stoel MG; de Man FHAF; Louwerenburg JHW; Hartmann M; Zocca P; Linssen GCM; van der Palen J; Doggen CJM; Löwik MM Lancet; 2016 Nov; 388(10060):2607-2617. PubMed ID: 27806902 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial. Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO; JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874 [TBL] [Abstract][Full Text] [Related]
9. Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: a case report. Terzioğlu K; Ediger D; Tülümen Öztürk R; Durmuş E; Alışır MF Anatol J Cardiol; 2017 May; 17(5):412-413. PubMed ID: 28529288 [No Abstract] [Full Text] [Related]
10. Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment. Mullen L; Khand A Can J Cardiol; 2016 Jun; 32(6):830.e9-830.e10. PubMed ID: 26514750 [No Abstract] [Full Text] [Related]
11. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy. Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201 [TBL] [Abstract][Full Text] [Related]
12. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Iglesias JF; Heg D; Roffi M; Tüller D; Lanz J; Rigamonti F; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Valgimigli M; Jüni P; Windecker S; Pilgrim T J Am Heart Assoc; 2019 Nov; 8(22):e013607. PubMed ID: 31696762 [TBL] [Abstract][Full Text] [Related]
13. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Parsa E; Saroukhani S; Majlessi F; Poorhosseini H; Lofti-Tokaldany M; Jalali A; Salarifar M; Nematipour E; Alidoosti M; Aghajani H; Amirzadegan A; Kassaian SE Tex Heart Inst J; 2016 Apr; 43(2):126-30. PubMed ID: 27127426 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular outcomes associated with Ultrathin bioresorbable polymer sirolimus eluting stents versus thin, durable polymer everolimus eluting stents following percutaneous coronary intervention in patients with type 2 diabetes mellitus: A meta-analysis of published studies. Deng S; Yi X; Tian Z Medicine (Baltimore); 2020 Dec; 99(52):e23810. PubMed ID: 33350767 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236 [TBL] [Abstract][Full Text] [Related]
17. The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry. de la Torre Hernandez JM; Moreno R; Gonzalo N; Rivera R; Linares JA; Veiga Fernandez G; Gomez Menchero A; Garcia Del Blanco B; Hernandez F; Benito Gonzalez T; Subinas A; Escaned J Cardiovasc Revasc Med; 2019 Aug; 20(8):705-710. PubMed ID: 30414798 [TBL] [Abstract][Full Text] [Related]
18. Allergic recurrent coronary stent thrombosis: A mini-review of Kounis syndrome. Ferreira RM; Villela PB; Almeida JCG; Sampaio PPN; Albuquerque FN; Pinheiro FMC; França Filho W; Salles JABE; Mansur Filho J Cardiovasc Revasc Med; 2018; 19(7 Pt B):890-895. PubMed ID: 29576520 [TBL] [Abstract][Full Text] [Related]
19. Kounis Syndrome: A Sting to the Heart. Annabathula RV; Chandrasekhar MA; Peters LA Tex Heart Inst J; 2023 Jan; 50(1):. PubMed ID: 36695737 [TBL] [Abstract][Full Text] [Related]